The ASCO Annual Meeting is the world’s most prominent scientific gathering in the clinical oncology community, showcasing cutting-edge research in clinical oncology and advanced cancer therapies. This ...
Clinical trial data demonstrate that Cavhanza can be taken with or without food, offering patients greater administration convenience.
Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood ...
Asianet Newsable on MSN
ELVN stock on track for best week since March following FDA-aligned path for cancer drug development
As of March 2026, ELVN-001 produced meaningful responses in heavily pretreated patients, many of whom had already tried ...
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive updated phase I data from the Enable ...
Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people with a specific type of blood cancer get the best medicine for them. "The new ...
HOUSTON ― According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) ...
US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available ...
The ASCO Annual Meeting is the world’s most prominent scientific gathering in the clinical oncology community, showcasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results